ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

NIH Proposes Center for Cell Biology

February 19, 1993

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds

August 31, 2001